Masaki Kato

Hirakata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depression.

Trans-ancestry genome-wide association meta-analysis of antidepressant response to selective serotonin reuptake inhibitors in clinical studies of depression.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2026

Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI).

Factors associated with social functioning by relapse frequency in Japanese outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments for Schizophrenia in Psychiatric Clinics (MUSASI).

Journal: Psychological medicine

Published: May 28, 2026

Reduced pre-treatment isolated effective coherence between the dorsolateral prefrontal cortex and the subgenual anterior cingulate cortex as a potential predictive marker for remission following repetitive transcranial magnetic stimulation in major depressive disorder.

Reduced pre-treatment isolated effective coherence between the dorsolateral prefrontal cortex and the subgenual anterior cingulate cortex as a potential predictive marker for remission following repetitive transcranial magnetic stimulation in major depressive disorder.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Published: April 26, 2026

Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.

Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.

Journal: Schizophrenia (Heidelberg, Germany)

Published: April 03, 2026

Correction: Widespread 3'UTR capped RNAs derive from G-rich regions in proximity to AGO2 binding sites.

Correction: Widespread 3'UTR capped RNAs derive from G-rich regions in proximity to AGO2 binding sites.

Journal: BMC biology

Published: March 31, 2026

Association of baseline plasma NMDA receptor-related amino acid ratios with remission following antidepressant treatment in major depressive disorder.

Association of baseline plasma NMDA receptor-related amino acid ratios with remission following antidepressant treatment in major depressive disorder.

Journal: Journal of affective disorders

Published: March 31, 2026

Response to Durability of zuranolone in postpartum depression versus major depressive disorder.

Response to Durability of zuranolone in postpartum depression versus major depressive disorder.

Journal: Psychiatry and clinical neurosciences

Published: February 09, 2026

Analysis of depressive symptom trajectory patterns with zuranolone: Time-series clustering of Japanese Phase 2 and Phase 3 trial data.

Analysis of depressive symptom trajectory patterns with zuranolone: Time-series clustering of Japanese Phase 2 and Phase 3 trial data.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: January 15, 2026

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Journal: PCN reports : psychiatry and clinical neurosciences

Published: December 15, 2025

Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database.

Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database.

Journal: Neuropsychopharmacology reports

Published: December 03, 2025

Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.

Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.

Journal: CNS drugs

Published: October 22, 2025

Screening for novel factors involved in mouse early embryonic development using inhibitor libraries.

Screening for novel factors involved in mouse early embryonic development using inhibitor libraries.

Journal: Frontiers in cell and developmental biology

Published: June 09, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026